Raiseby Fusion42
Open Neurosoft Bioelectronics in the live dashboard →

Neurosoft Bioelectronics raises $7.5M seed

Neurosoft Bioelectronics raised $7.5M in seed funding, announced on 20 May 2026, led by Skybound Venture Capital, with participation from Protocol Labs, IAG Capital Partners, Connecticut Innovations. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

Swiss neurotechnology company developing minimally invasive brain-computer interface (BCI) platforms using soft and stretchable neural interfaces. Neurosoft Bioelectronics is based in Switzerland and currently at seed stage, operating in deeptech, healthtech, medtech.

Skybound Venture Capital is profiled on Raise, Fusion42's database of venture funds — where each investor's thesis, cheque size and other tracked backings can be followed. This funding event is a citable node in Fusion42's market graph: it links Neurosoft Bioelectronics's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur, Fusion42's AI co-founder, reasons over when benchmarking a founder's own raise against what is closing in the market right now.

Round details

CompanyNeurosoft Bioelectronics
Stageseed
Amount$7.5M
Announced20 May 2026
LeadSkybound Venture Capital
ParticipationProtocol Labs, IAG Capital Partners, Connecticut Innovations
Sourceannouncement ↗

Investing funds on Raise

Explore: Medtech · Seed · Switzerland

Frequently asked questions

How much did Neurosoft Bioelectronics raise?
Neurosoft Bioelectronics raised $7.5M in its seed round, announced 2026-05-20.
Who invested in Neurosoft Bioelectronics's seed round?
The round was led by Skybound Venture Capital, with participation from Protocol Labs, IAG Capital Partners and Connecticut Innovations.
What does Neurosoft Bioelectronics do?
Swiss neurotechnology company developing minimally invasive brain-computer interface (BCI) platforms using soft and stretchable neural interfaces.

Verified 22 June 2026 · Sources: public filings